Pulling data out of an electronic health record (EHR) to be analyzed can be difficult because that’s not what these systems were typically created to do, said Pamela Tobias, MS, RHIA, CHDA, administrator of oncology services at Lehigh Valley Health Network.
Pulling data out of an electronic health record (EHR) to be analyzed can be difficult because that’s not what these systems were typically created to do, said Pamela Tobias, MS, RHIA, CHDA, administrator of oncology services at Lehigh Valley Health Network.
Transcript
How does electronic health record data improve hospital processes?
So, EHR data, in and of itself, doesn’t make the improvement, we have to employ a team of people to pull data out of the system for us, analyze it, and then we need the human beings to actually operationalize those improvements. Some of the things that we’ve utilized EHR data for are looking at readmission rates, looking at excessive utilization of care, analyzing quality outcomes, and all of that has been placed in discrete data that we’re able to pull out.
But we’ve also found that sometimes you have to go back and create those data fields in order to do your deeper dive analysis as you’re working with some of these initiatives.
How difficult is it to get the data out of EHRs in order to analyze it and make it useable?
I think it really depends on which EHR system you have. I think for most people it’s very difficult, because EHRs, in and of themselves, are not typically designed to be data analytics systems or reporting systems. Oftentimes, you’ll have to purchase another module or additional bolt-on data analysis packages, and, then, obviously, you’ll need your experts who can do the programming and the writing to pull that information out.
I hope that in the future we’ll get to something a little bit more sophisticated where I can see a field on a screen and click and drag that and match it to another field on the screen so that in the real time, when I have that question or one of my clinical team members has a question, we’re actually able to—almost in the way a pivot table functions—grab that right out of the EHR system on the front end without having to put in a report request, wait for that to come back. Because by then maybe a different urgent need has come up and pulled us away from the initial one.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More